Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication

Junko Murai1,2,3,4, Michele Ceribelli5, Haiqing Fu1

  • 1Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.

Insights

Schlafen 11 (SLFN11) is a predictive biomarker for cancer drugs. New research shows SLFN11 inhibits unscheduled re-replication caused by pevonedistat, enhancing anticancer efficacy and suggesting SLFN11 as a biomarker for pevonedistat treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Schlafen 11 (SLFN11) is a key predictive biomarker and molecular sensor for various anticancer drugs, including topoisomerase, PARP, replication inhibitors, and platinum derivatives.
  • Expanding the therapeutic targets and drug spectrum associated with SLFN11 is crucial for advancing cancer treatment strategies.

Purpose of the Study:

  • To identify novel drugs and pathways that target SLFN11 by conducting a high-throughput screen.
  • To investigate the mechanism by which pevonedistat and AHPN/CD437 interact with SLFN11 and influence cancer cell viability.
  • To establish SLFN11 as a predictive biomarker for pevonedistat in cancer therapy.

Main Methods:

  • A high-throughput screen of 1,978 oncology-focused compounds was performed using isogenic cell pairs proficient and deficient in SLFN11.
  • Compounds inducing selective killing of SLFN11-proficient cells were identified, including known DNA-targeting agents, pevonedistat, and AHPN/CD437.
  • SLFN11 recruitment to chromatin and its role in regulating unscheduled re-replication upon pevonedistat treatment were analyzed.

Main Results:

  • Twenty-nine hit compounds selectively killed SLFN11-proficient cells, including the neddylation inhibitor pevonedistat and the DNA polymerase α inhibitor AHPN/CD437.
  • Pevonedistat and AHPN/CD437 induced SLFN11 chromatin recruitment, with pevonedistat showing a delayed recruitment (24 hours) compared to other agents (4 hours).
  • SLFN11 inhibited pevonedistat-induced unscheduled re-replication, enhancing anticancer efficacy, and a positive correlation between SLFN11 expression and pevonedistat sensitivity was observed across multiple cancer cell databases.

Conclusions:

  • SLFN11 functions not only as a sensor for replication stress but also actively inhibits unscheduled re-replication induced by pevonedistat, thereby potentiating its anticancer effects.
  • The findings support SLFN11 as a potential predictive biomarker for pevonedistat, guiding its use in current and future clinical trials.
  • This study expands the known drug targets and pathways influenced by SLFN11, offering new avenues for cancer therapy development.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
4.7K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.9K
What is the Cell Cycle?00:56

What is the Cell Cycle?

The cell cycle refers to the sequence of events occurring throughout a typical cell’s life. In eukaryotic cells, the somatic cell cycle has two stages: the interphase and the mitotic phase. During interphase, the cell grows, performs its basic metabolic functions, copies its DNA, and prepares for mitotic cell division. Then, during mitosis and cytokinesis, the cell divides its nuclear and cytoplasmic materials, respectively. This generates two daughter cells that are identical to the...
6.6K